Data updated: Mar 10, 2026
IMPLANON
ETONOGESTREL
Approved 2006-07-17
3
Indications
--
Phase 3 Trials
19
Years on Market
Details
- Status
- Discontinued
- First Approved
- 2006-07-17
- Routes
- IMPLANTATION
- Dosage Forms
- IMPLANT
IMPLANON Approval History
Loading approval history...
What IMPLANON Treats
3 FDA approvalsOriginally approved for its first indication in 2006 . Covers 3 distinct patient populations.
- Other (3)
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
IMPLANON FDA Label Details
ProIMPLANON Patents & Exclusivity
Latest Patent: Jul 2030
Patents (5 active)
US9757552
Expires Jul 28, 2030
US8722037
Expires Sep 28, 2027
US10821277
Expires May 31, 2027
US8888745
Expires Aug 28, 2026
Source: FDA Orange Book
Want competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.